Clinical Trial Update: RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for RESET-MS, a Phase 1/Phase 2 study evaluating CABA-201 in relapsing-remitting and progressive multiple sclerosis, with status not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• CABA-201

Snippet

Sponsor: Cabaletta Bio | Conditions: Relapsing Multiple Sclerosis (RMS), Progressive Multiple Sclerosis (PMS) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING